View all newsletters
Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat…
ByGlaxoSmithKline (GSK) has exercised the option to obtain an exclusive global licence from Adaptimmune Therapeutics for an investigational SPEAR…
ByUS-based Regeneron Pharmaceuticals and French company Sanofi have received breakthrough therapy designation status for cemiplimab (REGN2810) from the US…
By
US biotechnology company Bioverativ has entered a new research collaboration with UK-based Bicycle Therapeutics to discover, develop and commercialise…
ByGermany-based Boehringer Ingelheim has entered a collaboration and licensing agreement with Danish biotech company Gubra to develop new peptide…
ByThe US National Institutes of Health (NIH) has awarded nine research grants worth around $100m over the next five…
ByFrench pharmaceutical company Sanofi and Italian biotech firm Axxam have entered a new research collaboration in the field of…
ByMerck is set to acquire German biotechnology firm Rigontec for an upfront cash payment of €115m.
By
Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson & Johnson, has received US Food and Drug Administration (FDA)…
By